Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2026

Earnings Per Share [Abstract]

Schedule of Net Loss Per Share, Basic and Diluted

The following table sets forth the reconciliation of the numerator used to compute basic and diluted net loss per share of Class A common stock for the three months ended March 31, 2026 and 2025.


	Three Months Ended March 31,
(in thousands)	2026				2025
Numerator:
Net loss	$	(192,354	)		$	(155,093	)
Less: Net loss attributable to noncontrolling interests		(53,733	)			(47,865	)
Net loss attributable to Definitive Healthcare Corp.	$	(138,621	)		$	(107,228	)

The following table sets forth the computation of basic and diluted net loss per share of Class A common stock for the three months ended March 31, 2026 and 2025 (per share amounts unaudited).


	Three Months Ended March 31,
(in thousands, except number of shares and per share amounts)	2026				2025
Basic and diluted net loss per share attributable to common stockholders
Numerator:
Allocation of net loss attributable to Definitive Healthcare Corp.	$	(138,621	)		$	(107,228	)
Denominator:
Weighted average number of shares of Class A common stock outstanding		104,675,068				112,782,505
Net loss per share, basic and diluted	$	(1.32	)		$	(0.95	)

Schedule of Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share

The following table presents potentially dilutive securities excluded from the computation of diluted net loss per share for the period presented because their effect would have been anti-dilutive:


	Three Months Ended March 31,
	2026				2025
Definitive OpCo LLC Units (vested and unvested)		38,225,333				38,997,184
Restricted Stock Units		22,613,338				13,435,809